These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting. Smith CC; Bernstein LI; Davis RB; Rind DM; Shmerling RH Arch Intern Med; 2003 Mar; 163(6):688-92. PubMed ID: 12639201 [TBL] [Abstract][Full Text] [Related]
33. Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Simard C; Poirier P Can J Cardiol; 2006 Feb; 22(2):141-4. PubMed ID: 16485049 [TBL] [Abstract][Full Text] [Related]
34. Worsening myopathy associated with ezetimibe in a patient with McArdle disease. Perez-Calvo J; Civeira-Murillo F; Cabello A QJM; 2005 Jun; 98(6):461-2. PubMed ID: 15897216 [No Abstract] [Full Text] [Related]
35. Succinylcholine should be avoided in patients on statin therapy. Lee C Anesthesiology; 2011 Jul; 115(1):6-7. PubMed ID: 21587061 [No Abstract] [Full Text] [Related]
36. Neuromuscular symptoms and elevated creatine kinase after statin withdrawal. Echaniz-Laguna A; Mohr M; Tranchant C N Engl J Med; 2010 Feb; 362(6):564-5. PubMed ID: 20147729 [No Abstract] [Full Text] [Related]
38. Strategies for the prevention and treatment of statin-induced myopathy: is there a role for ubiquinone supplementation? Koumis T; Nathan JP; Rosenberg JM; Cicero LA Am J Health Syst Pharm; 2004 Mar; 61(5):515-9. PubMed ID: 15018231 [No Abstract] [Full Text] [Related]